Fresenius Kabi USA, LLC vs. Amgen Inc
Explore the PTAB proceeding IPR2019-01183 filed by Fresenius Kabi USA, LLC on 2019-06-08. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2019-01183
Filing Date
2019-06-08
Accorded Filing Date
2019-06-08
Institution Decision Date
2019-12-10
Last Modified Date
2020-06-23
Proceeding Type
IPR
Termination Date
2020-06-23
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Fresenius Kabi USA, LLC
Represented By
Huiya WuPatent Owner / Respondent
Amgen Inc
Represented By
J. Steven BaughmanPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32511 | Stuart Watt | +1 805-447-2154 |
| 36964 | Wendy Whiteford | +1 805-447-1008 |
| 38496 | Petrina Hsi | +1 805-447-8631 |
| 41156 | Susan Lingenfelter | +1 805-313-3010 |
| 41576 | Lisa Alexander | +1 650-244-2968 |
| 44412 | Henry Wu | +1 805-447-0781 |
| 44689 | Bernard Friedrichsen | +1 805-447-0628 |
| 45590 | Randolph Mohr | +1 805-447-8949 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,643,997 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,577,392 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,407,784 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,312,381 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 22,047,709 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,940,878 B2 | US Continuation / Sibling | View Official Patent → |
Kashiv BioSciences, LLC v. Amgen Inc.
Amgen Inc. v. Hospira, Inc.